Generate Investment Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Generate Investment Management's VRTX Position: Q2 2026 in Review
Generate Investment Management increased its Vertex Pharmaceuticals (VRTX) stake by 150% in Q2 2026, buying an estimated $419K and bringing the position to 1,573 shares worth $781K. The position accounts for 0.03% of the portfolio, ranked #88.
Generate Investment Management first reported a position in VRTX in Q4 2023 and has held it in 6 quarters since. The position peaked at $11.9M in Q4 2025. 1,762 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Generate Investment Management held 1,573 shares of Vertex Pharmaceuticals worth $781K as of Q2 2026.
- Generate Investment Management bought 945 Vertex Pharmaceuticals shares in Q2 2026, an estimated $419K.
- Vertex Pharmaceuticals made up 0.03% of Generate Investment Management's portfolio in Q2 2026, its #88 holding.
- Generate Investment Management first reported a position in Vertex Pharmaceuticals in Q4 2023 and has held it in 6 quarters since.
- Generate Investment Management's Vertex Pharmaceuticals position peaked at $11.9M in Q4 2025.
- 1,762 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Generate Investment Management's 13F filing for Q2 2026, filed 27 Jul 2026.